Question 1

What does Opus Genetics(formerly Ocuphire Pharma) do?

Accepted Answer

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Question 2

In what sectors does Opus Genetics(formerly Ocuphire Pharma) operate?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) operates in Biopharma, Biotechnology, Pharmaceutical.

Question 3

How many companies has Opus Genetics(formerly Ocuphire Pharma) acquired?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) has made 2 acquisitions between 2020-2024, with a total disclosed deal value of $25.8M.

Question 4

What companies are owned by Opus Genetics(formerly Ocuphire Pharma)?

Accepted Answer

Companies acquired by Opus Genetics(formerly Ocuphire Pharma) include Opus Genetics, Rexahn Pharmaceuticals.

Question 5

What are Opus Genetics(formerly Ocuphire Pharma)'s major acquisitions?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma)'s largest acquisitions include Opus Genetics ($25.8M, 2024).

Question 6

What is Opus Genetics(formerly Ocuphire Pharma)'s largest acquisition?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma)'s largest disclosed acquisition is Opus Genetics for $25.8M (2024).

Question 7

What was Opus Genetics(formerly Ocuphire Pharma)'s first acquisition?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma)'s first recorded acquisition was Rexahn Pharmaceuticals in 2020.

Question 8

What was Opus Genetics(formerly Ocuphire Pharma)'s most recent acquisition?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma)'s most recent acquisition is Opus Genetics, announced October 2024 for $25.8M.

Question 9

What is the average deal size for Opus Genetics(formerly Ocuphire Pharma) acquisitions?

Accepted Answer

The average disclosed deal size for Opus Genetics(formerly Ocuphire Pharma) acquisitions is $25.8M.

Question 10

What is the median deal size for Opus Genetics(formerly Ocuphire Pharma) acquisitions?

Accepted Answer

The median disclosed deal size for Opus Genetics(formerly Ocuphire Pharma) acquisitions is $25.8M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Opus Genetics(formerly Ocuphire Pharma) spent on acquisitions?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) has spent at least $25.8M across its disclosed acquisitions (of 2 total deals; some prices are undisclosed).

Question 12

Which sector has Opus Genetics(formerly Ocuphire Pharma) spent the most on?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) has committed the most disclosed capital to Biopharma companies — about $25.8M across its deals in that sector.

Question 13

What sectors does Opus Genetics(formerly Ocuphire Pharma) usually acquire in?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) most frequently acquires companies in Biopharma, Genetics, Health Care.

Question 14

In which sector has Opus Genetics(formerly Ocuphire Pharma) made the most acquisitions?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) has made the most acquisitions in the Biopharma sector.

Question 15

In which year did Opus Genetics(formerly Ocuphire Pharma) make the most acquisitions?

Accepted Answer

Opus Genetics(formerly Ocuphire Pharma) made the most acquisitions in 2024, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Opus Genetics(formerly Ocuphire Pharma)

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Opus Genetics(formerly Ocuphire Pharma)

Explore 200,000+ acquisitions — free

Recent News related to Opus Genetics(formerly Ocuphire Pharma)

FAQs about Opus Genetics(formerly Ocuphire Pharma)

People who checked this page also checked these